glp-1 discontinuation rates and Reinitiation of Dual-Labeled Receptor Agonists Among US Adults With Overweight or Obesity Association of GLP-1RA discontinuation and

These hallmarks of aging satisfy three conditions: (i) they become apparent with advancing age, (ii) experimentally perturbing them causes poor aging (iii) therapeutically intervening upon them prevents, delays or reverses aging phenotypes

Proven Benefits of GLP-1 Receptor Agonists The mechanism by which GLP-1 receptor agonists such as Ozempic and Wegovy work, as described above, facilitates the following benefits: Blood Sugar Control GLP-1 receptor agonists, like Ozempic , effectively lower blood sugar by enhancing insulin sensitivity, boosting insulin release, and decreasing liver glucose production

Many people maintain results with periodic maintenance sessions rather than expecting a one time permanent change

2017;97(Pt B):11926

Low circulating IGF-1 levels are associated with increased risk of insulin resistance, metabolic syndrome, and type 2 diabetes development